Selected research
Industry Growth & Trends
Global Botanical and Herbal Drug Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Botanical and Herbal Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Botanical and Herbal Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Botanical and Herbal Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Botanical and Herbal Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Botanical and Herbal Drug market include China TCM, Yunnan Baiyao, Tong Ren Tang, Kwangdong, Guangzhou Baiyunshan Pharmaceutical, Weleda, Tsumura, Tasly Holding Group and Taiji, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Botanical and Herbal Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Botanical and Herbal Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Botanical and Herbal Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Botanical and Herbal Drug.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Botanical and Herbal Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Botanical and Herbal Drug Market by Company
China TCM
Yunnan Baiyao
Tong Ren Tang
Kwangdong
Guangzhou Baiyunshan Pharmaceutical
Weleda
Tsumura
Tasly Holding Group
Taiji
Schwabe
Jumpcan Pharmaceutical
Huarun 999
GW Pharmaceuticals
Buchang Pharmaceuticals
Bionorica Se
Botanical and Herbal Drug Segment by Type
Prescription Drug
OTC
Botanical and Herbal Drug Segment by Application
Respiratory System
Cardiovascular
Tumor
Other
Botanical and Herbal Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Botanical and Herbal Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Botanical and Herbal Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Botanical and Herbal Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Botanical and Herbal Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Prescription Drug
- OTC
Applications
- Respiratory System
- Cardiovascular
- Tumor
- Other
Companies covered
- China TCM
- Yunnan Baiyao
- Tong Ren Tang
- Kwangdong
- Guangzhou Baiyunshan Pharmaceutical
- Weleda
- Tsumura
- Tasly Holding Group
- Taiji
- Schwabe
- Jumpcan Pharmaceutical
- Huarun 999
- GW Pharmaceuticals
- Buchang Pharmaceuticals
- Bionorica Se
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Botanical and Herbal Drug Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Botanical and Herbal Drug Market Size by Region (2021-2032)
- 1.4.1 Global Botanical and Herbal Drug Market Size by Region (2021-2026)
- 1.4.2 Global Botanical and Herbal Drug Market Size by Region (2027-2032)
- 1.5 Key Regions Botanical and Herbal Drug Market Size (2021-2032)
- 1.5.1 North America Botanical and Herbal Drug Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Botanical and Herbal Drug Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Botanical and Herbal Drug Market Size Growth Rate (2021-2032)
- 1.5.4 South America Botanical and Herbal Drug Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Botanical and Herbal Drug Market Size Growth Rate (2021-2032)
2 Botanical and Herbal Drug Market by Type
- 2.1 Type Introduction
- 2.1.1 Prescription Drug
- 2.1.2 OTC
- 2.2 Global Botanical and Herbal Drug Market Size by Type
- 2.2.1 Global Botanical and Herbal Drug Market Size Overview by Type (2021-2032)
- 2.2.2 Global Botanical and Herbal Drug Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Botanical and Herbal Drug Market Size Forecasted by Type (2027-2032)
- 2.3 Global Botanical and Herbal Drug Market Size by Regions
- 2.3.1 North America Botanical and Herbal Drug Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Botanical and Herbal Drug Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Botanical and Herbal Drug Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Botanical and Herbal Drug Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Botanical and Herbal Drug Market Size Breakdown by Type (2021-2026)
3 Botanical and Herbal Drug Market by Application
- 3.1 Type Introduction
- 3.1.1 Respiratory System
- 3.1.2 Cardiovascular
- 3.1.3 Tumor
- 3.1.4 Other
- 3.2 Global Botanical and Herbal Drug Market Size by Application
- 3.2.1 Global Botanical and Herbal Drug Market Size Overview by Application (2021-2032)
- 3.2.2 Global Botanical and Herbal Drug Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Botanical and Herbal Drug Market Size Forecasted by Application (2027-2032)
- 3.3 Global Botanical and Herbal Drug Market Size by Regions
- 3.3.1 North America Botanical and Herbal Drug Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Botanical and Herbal Drug Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Botanical and Herbal Drug Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Botanical and Herbal Drug Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Botanical and Herbal Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Botanical and Herbal Drug Industry Trends
- 4.2 Botanical and Herbal Drug Industry Drivers
- 4.3 Botanical and Herbal Drug Industry Opportunities and Challenges
- 4.4 Botanical and Herbal Drug Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Botanical and Herbal Drug Revenue (2021-2026)
- 5.2 Global Botanical and Herbal Drug Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Botanical and Herbal Drug Key Company Headquarters & Area Served
- 5.4 Global Botanical and Herbal Drug Company, Product Type & Application
- 5.5 Global Botanical and Herbal Drug Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Botanical and Herbal Drug Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Botanical and Herbal Drug Players Market Share by Revenue in 2025
- 5.6.3 2025 Botanical and Herbal Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 China TCM
- 6.1.1 China TCM Company Information
- 6.1.2 China TCM Business Overview
- 6.1.3 China TCM Botanical and Herbal Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 China TCM Botanical and Herbal Drug Product Portfolio
- 6.1.5 China TCM Recent Developments
- 6.2 Yunnan Baiyao
- 6.2.1 Yunnan Baiyao Company Information
- 6.2.2 Yunnan Baiyao Business Overview
- 6.2.3 Yunnan Baiyao Botanical and Herbal Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Yunnan Baiyao Botanical and Herbal Drug Product Portfolio
- 6.2.5 Yunnan Baiyao Recent Developments
- 6.3 Tong Ren Tang
- 6.3.1 Tong Ren Tang Company Information
- 6.3.2 Tong Ren Tang Business Overview
- 6.3.3 Tong Ren Tang Botanical and Herbal Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Tong Ren Tang Botanical and Herbal Drug Product Portfolio
- 6.3.5 Tong Ren Tang Recent Developments
- 6.4 Kwangdong
- 6.4.1 Kwangdong Company Information
- 6.4.2 Kwangdong Business Overview
- 6.4.3 Kwangdong Botanical and Herbal Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Kwangdong Botanical and Herbal Drug Product Portfolio
- 6.4.5 Kwangdong Recent Developments
- 6.5 Guangzhou Baiyunshan Pharmaceutical
- 6.5.1 Guangzhou Baiyunshan Pharmaceutical Company Information
- 6.5.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
- 6.5.3 Guangzhou Baiyunshan Pharmaceutical Botanical and Herbal Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Guangzhou Baiyunshan Pharmaceutical Botanical and Herbal Drug Product Portfolio
- 6.5.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
- 6.6 Weleda
- 6.6.1 Weleda Company Information
- 6.6.2 Weleda Business Overview
- 6.6.3 Weleda Botanical and Herbal Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Weleda Botanical and Herbal Drug Product Portfolio
- 6.6.5 Weleda Recent Developments
- 6.7 Tsumura
- 6.7.1 Tsumura Company Information
- 6.7.2 Tsumura Business Overview
- 6.7.3 Tsumura Botanical and Herbal Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Tsumura Botanical and Herbal Drug Product Portfolio
- 6.7.5 Tsumura Recent Developments
- 6.8 Tasly Holding Group
- 6.8.1 Tasly Holding Group Company Information
- 6.8.2 Tasly Holding Group Business Overview
- 6.8.3 Tasly Holding Group Botanical and Herbal Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Tasly Holding Group Botanical and Herbal Drug Product Portfolio
- 6.8.5 Tasly Holding Group Recent Developments
- 6.9 Taiji
- 6.9.1 Taiji Company Information
- 6.9.2 Taiji Business Overview
- 6.9.3 Taiji Botanical and Herbal Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Taiji Botanical and Herbal Drug Product Portfolio
- 6.9.5 Taiji Recent Developments
- 6.10 Schwabe
- 6.10.1 Schwabe Company Information
- 6.10.2 Schwabe Business Overview
- 6.10.3 Schwabe Botanical and Herbal Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Schwabe Botanical and Herbal Drug Product Portfolio
- 6.10.5 Schwabe Recent Developments
- 6.11 Jumpcan Pharmaceutical
- 6.11.1 Jumpcan Pharmaceutical Company Information
- 6.11.2 Jumpcan Pharmaceutical Business Overview
- 6.11.3 Jumpcan Pharmaceutical Botanical and Herbal Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Jumpcan Pharmaceutical Botanical and Herbal Drug Product Portfolio
- 6.11.5 Jumpcan Pharmaceutical Recent Developments
- 6.12 Huarun 999
- 6.12.1 Huarun 999 Company Information
- 6.12.2 Huarun 999 Business Overview
- 6.12.3 Huarun 999 Botanical and Herbal Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Huarun 999 Botanical and Herbal Drug Product Portfolio
- 6.12.5 Huarun 999 Recent Developments
- 6.13 GW Pharmaceuticals
- 6.13.1 GW Pharmaceuticals Company Information
- 6.13.2 GW Pharmaceuticals Business Overview
- 6.13.3 GW Pharmaceuticals Botanical and Herbal Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 GW Pharmaceuticals Botanical and Herbal Drug Product Portfolio
- 6.13.5 GW Pharmaceuticals Recent Developments
- 6.14 Buchang Pharmaceuticals
- 6.14.1 Buchang Pharmaceuticals Company Information
- 6.14.2 Buchang Pharmaceuticals Business Overview
- 6.14.3 Buchang Pharmaceuticals Botanical and Herbal Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Buchang Pharmaceuticals Botanical and Herbal Drug Product Portfolio
- 6.14.5 Buchang Pharmaceuticals Recent Developments
- 6.15 Bionorica Se
- 6.15.1 Bionorica Se Company Information
- 6.15.2 Bionorica Se Business Overview
- 6.15.3 Bionorica Se Botanical and Herbal Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Bionorica Se Botanical and Herbal Drug Product Portfolio
- 6.15.5 Bionorica Se Recent Developments
7 North America
- 7.1 North America Botanical and Herbal Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Botanical and Herbal Drug Market Size by Country (2021-2026)
- 7.3 North America Botanical and Herbal Drug Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Botanical and Herbal Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Botanical and Herbal Drug Market Size by Country (2021-2026)
- 8.3 Europe Botanical and Herbal Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Botanical and Herbal Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Botanical and Herbal Drug Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Botanical and Herbal Drug Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Botanical and Herbal Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Botanical and Herbal Drug Market Size by Country (2021-2026)
- 10.3 South America Botanical and Herbal Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Botanical and Herbal Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Botanical and Herbal Drug Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Botanical and Herbal Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst